학술논문
Randomized phase II study of gemcitabine plus cisplatin, with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer.
Document Type
Journal Article
Author
Source
Journal of Clinical Oncology; 12/20/2007, Vol. 25 Issue 36, p5777-5784, 8p
Subject
Language
ISSN
0732183X